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Abstract
Background: Cervicitis is a syndrome of cervical inflammation and a common condition in female sex workers
(FSW), a subpopulation vulnerable to sexually transmitted infections. Local data is essential for guiding syndromic
management of cervicitis in FSW working in Peru. We sought to describe the prevalence and etiologies of cervicitis
in this population. We also aimed to identify sociodemographic, behavioral and biological factors associated with
cervicitis, including bacterial vaginosis (BV), a condition with a possible role in cervicitis.
Methods: FSW 18 years of age or older presenting to a free public sexual health clinic in Callao-Lima, Peru were
eligible for inclusion upon consent. 467 participants completed a face-to-face questionnaire and underwent genital
examination. Vaginal, endocervical and blood samples were collected and tested for C. trachomatis (CT), N.
gonorrhea (GC), T. vaginalis (TV), BV, HIV and Human T-Cell Lymphotropic Virus −1. Logistic regression was used to
determine whether sociodemographic, behavioral, or other sexual health related characteristics were associated
with the diagnosis of cervicitis.
Results: Cervicitis was detected in 99 (24.9%) of 397 FSW. The presence of cervicitis was unable to be determined
in 70 participants. In women with cervicitis, CT was present in 4.6% (4/87), TV in 4.0% (4/99), GC in 0% (0/87) and no
pathogen was detected on cervical microbiology in 91.9% (91/99). BV was detected on vaginal microbiology in
36.9% (31/84) of cervicitis cases. BV was more common in women with cervicitis, however this association did not
reach statistical significance (aOR = 1.47 [0.87, 2.48], p = 0.15). Other STI were not associated with cervicitis. Regular
clinic attendance (aOR = 0.54 [0.34, 0.87], p = 0.01) and Ecuadorian nationality (aOR = 0.31 [0.13, 0.76], p = 0.01) were
associated with reduced risk of cervicitis.
Conclusions: Cervicitis was common in FSW working Peru and was predominantly nongonococcal and non-
chlamydial in etiology. Further study is warranted to clarify the role of BV and other emerging cervicitis pathogens
in this population. The current Peruvian program of free health checks for FSW may be effective for reducing rates
of cervicitis. The protective effect of Ecuadorian nationality prompts further study.
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Background
Cervicitis is a syndrome of cervical inflammation and a
common manifestation of sexually transmitted infections
(STI) such as Chlamydia trachomatis (CT) and Neisseria
gonorrhoea (GC) [1,2]. Vaginal discharge or intermenstrual
bleeding are frequent symptoms of cervicitis, although it
may be asymptomatic [1,3]. Cervicitis can progress to
pelvic inflammatory disease (PID) with severe reproduct-
ive sequelae, even in asymptomatic cases [3]. Cervicitis
may also affect sexual health at a population level, as it in-
creases shedding of other STI such as Human Immuno-
deficiency Virus (HIV) and Human T-cell Lymphotropic
Virus (HTLV) [4,5].
While cervicitis is considered to arise as a consequence
of STI, understanding of its etiology and pathogenesis is
still evolving. Even with advanced microbiological assays,
no causative pathogen is identified in the majority of cervi-
citis cases. When a pathogen is detected, CT and GC are
the usual culprits. Less commonly, Mycoplasma genitalium,
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Trichomonas vaginalis (TV) and Herpes simplex Virus
(HSV) are implicated [1,2]. More recently, bacterial vagin-
osis (BV) has been linked to cervicitis, in addition to an
increased risk of HIV acquisition, adverse pregnancy out-
comes and gynaecological surgery complications [3,6]. Al-
though not an STI per se, BV is an endogenous vaginitis
associated with sexual activity and characterized by an
overgrowth of vaginal anaerobic flora and reduction of
H202-producing lactobacilli [3].
Cervicitis is a common condition in FSW, with preva-
lences as high as 20% [7]. In studies of cervicitis in FSW
living in Africa, CT, GC, M. genitalium and TV were com-
mon pathogens [7-9]. Factors such as lower education
level, greater numbers of clients and decreased condom
usage were associated with cervical infection in FSW
working in Madagascar [10]. Although cervicitis has been
reported in Peruvian FSW, detailed data regarding the
prevalence, etiologies and risk factors for cervicitis in
FSW working in Peru or other Latin American coun-
tries is lacking [4,11]. As FSW may receive only inter-
mittent healthcare and advanced diagnostics in low
resource settings are limited, cervicitis in FSW, when
diagnosed, is most often treated syndromically [12].
Syndromic management has drawbacks such as the un-
derdiagnosis of subclinical STI and a potential overuse
of antimicrobials [13]. Since FSW are particularly vul-
nerable to STI, and cervicitis may increase rates of STI
transmission to the general population, accurate local
epidemiological data is essential for guiding syndromic
management of cervicitis in FSW.
The objectives of this observational, cross-sectional
study were to describe the prevalence and etiologies of
cervicitis in FSW receiving care at a public health clinic
and associated mobile clinic in Callao-Lima, Peru. We
also sought to identify sociodemographic, behavioral and
biological factors associated with cervicitis. In particular,
we sought to determine if an association between BV
and cervicitis existed in these women, particularly given
the high reported rates of BV in Peruvian FSW [11].
Methods
Setting, study participants & enrolment
In Peru, sex work is permitted by FSW who are registered
at a public health clinic and are of 18 years of age or older.
Registration requires monthly health assessments which
are free of charge, including treatment [11]. Approxi-
mately two-thirds of Lima’s estimated 15,000 FSW are
registered. The Centro de Salud ‘Alberto Barton’ (CSAB),
located in the port city of Callao-Lima, provides
healthcare to registered FSW, while an associated mobile
clinic provides care to unregistered FSW. These monthly
healthcare checks are provided by Peruvian Ministry of
Health clinicians, and include genital examination and
collection of cervical and vaginal swabs for basic onsite
microbiology (including Gram stain, wet mount and
KOH staining) in addition to gonococcal culture. Syphilis
screening (by non-treponemal assay) is performed
quarterly and HIV testing is performed twice per year.
If required, much of the treatment is syndromic as per
the National STI Guidelines [11].
FSW presenting for medical assessment at either of these
clinics between November 2008 and January 2011 were in-
vited to participate in this cross-sectional study. Unregis-
tered and registered FSW were eligible to participate, with
registration status determined on routine assessment. Un-
registered FSW were offered enrolment (if eligible) when
presenting for routine assessment at the mobile clinic.
FSW 18 years of age or older were eligible for inclusion.
Informed consent was obtained from all study participants.
The study was approved by the Institutional Review
Boards of the University of Washington, Universidad
Nacional Mayor de San Marcos, the Directorate of
Callao, and US Naval Medical Research Unit No. 6
(NAMRU-6), Callao, Peru.
Study procedures
All participants completed a face-to-face questionnaire to
provide data on sociodemographic and behavioral vari-
ables and underwent genital examination with collection
of vaginal, endocervical and blood samples. Genital exam-
ination was performed by one of the regular clinic doctors
as an assigned study physician. Cervicitis was defined as
the presence of mucopus and friability in concurrence
with the Centers for Disease Control and Prevention rec-
ommendations [3]. PID was defined as cervicitis in the
presence of lower abdominal pain plus cervical motion
tenderness, adnexal tenderness or uterine tenderness.
Saline wet-mount microscopy was performed on cervical
samples for detection of Trichomonas vaginalis (TV) at an
on-site laboratory at CSAB. Further cervical specimen test-
ing occurred at NAMRU-6 laboratories in Lima, Peru. One
cervical sample was placed in specimen transport medium
(Digene Diagnostics, Silver Spring, MD) for molecular test-
ing of Chlamydia trachomatis (CT), Neisseria gonorrhoea
(GC) and Human Papillomavirus (HPV). CT and GC test-
ing was performed using Amplicor CT/GC PCR according
to the manufacturer’s instructions (Roche, Pleasanton,
California, USA). HPV DNA was extracted and PCR
analysis performed according to methods described
elsewhere [14]. Vaginal swabs were evaluated with
Gram stain, KOH and saline wet mount tests for the de-
tection of candidiasis, TV and BV. In accordance with
recently standardised research definitions, BV was diag-
nosed by positive Amsel criteria and Nugent scoring [15].
All vaginal swab testing occurred at CSAB.
Blood samples were transported to NAMRU-6 labora-
tories for analysis. Serum was screened for HIV using a
Vironostika HIVAg/Ab assay (bioMeriéux, Marcy l′Etoile,
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Table 1 Sociodemographic, behavioral and biological characteristics in FSW with and without cervicitisa
FSW with cervicitis (n = 99) FSW without cervicitis (n = 298) p-value
Age, median years (IQRb) 30 (24–38) 27 (23–33) 0.02
Age at initiation of sex work, median years (IQR) 22 (20–27) 22 (19–27) 0.32
Time in sex work, median months (IQR) 36 (10–132) 24 (6–72) 0.03
n % n %
Nationality 0.01
Peruvian 90 90.9 228 76.5
Other countriesc 9 9.1 70 23.5
Registration status 0.01
Registered 40 40.4 102 34.2
Unregistered 33 33.3 55 18.5
Place of work 0.07
Legal brothel 40 65.6 178 77.1
Otherd 21 34.4 53 22.9
Number of clients in last week 0.04
None 35 36.1 101 35.7 Ref
1 to 10 29 29.9 59 20.9 0.24
11 to 20 19 19.6 35 12.4 0.19
21 to 40 7 7.2 43 15.2 0.10
> 40 7 7.2 45 15.9 0.08
Most frequent sexual practices
with clients
0.42
Vaginal 8 8.3 12 4.2 0.14
Vaginal and oral 70 72.9 211 74.6 Ref
Vaginal, oral and anal 18 18.8 59 20.9 0.78
Has a non-client sexual partner 65 34.3 170 57.8 0.17
Oral contraceptive pill use 19 80.8 52 17.7 0.74
Condom use with clients 0.21
Always 75 78.0 234 83.0 Ref
Between rarely and almost always 10 10.5 15 5.3 0.09
Never 10 10.5 33 11.7 0.88
Sexually transmitted/genital tract infections
Syphilis 0 0.0 5 1.7 0.20
Chlamydia trachomatis (CT) 4 4.6 11 4.9 0.91
Neisseria gonorrhea (GC) 0 0.0 1 0.4 0.53
Trichomonas vaginalis (TV) 4 4.0 2 0.7 0.02
Human Papillomavirus (HPV) 48 48.5 140 47.0 0.80
Human Immunodeficiency Virus (HIV) 1 1.0 2 0.7 0.74
Human T-cell Lymphotropic Virus (HTLV) 3 3.0 5 1.7 0.41
Bacterial vaginosis 31 36.9 74 28.0 0.12
Candidiasis 7 7.1 19 6.5 0.83
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France); positive assays were confirmed by line immu-
noblot assay (INNO-LIA HIV I/II Score, Innogenetics,
Gent, Belgium). Serum samples were also tested for
HTLV-1/2 antibody by ELISA assay (BioElisa HTLV I/II
5.0 BioKit, Llica d’Amunt, Barcelona, Spain) with con-
firmatory testing using line immunoblot assay (HTLV I/II
score, Innogenetics, Gent, Belgium). Serum was screened
for syphilis using Rapid Plasma Reagin (RPR-nosticon II,
bioMeriéux, Marcy l′Etoile, France) and confirmed by
Treponema Pallidum Hemagglutination Assay (TPHA;
Syphagen TPHA - Biokit, Llica d’Amunt, Barcelona,
Spain). Women with positive STI test results were
counselled and treated according to Peruvian Ministry
of Health Guidelines [11].
Statistical analysis
All data were double entered into an electronic database
and analyzed using STATA, version 12.0 (StataCorp,
College Station, TX). Bivariate associations of cervicitis
with sociodemographic, behavioral, and biological vari-
ables were examined using Chi-squared tests to determine
significant differences between groups. Logistic regression
was used to determine whether sociodemographic, behav-
ioral, or other sexual health-related characteristics were
associated with the diagnosis of cervicitis. Both unadjusted
and adjusted logistic models were fit to estimate odds
ratios (OR) and 95% confidence intervals (95% CI). For
sociodemographic variables, we used the criterion of a
greater than 10% change in the OR to identify confounders
in adjusted models. For biological variables, we specified
the presence of genital tract infections associated with
both cervicitis and bacterial vaginosis (namely CT, GC or
TV) as a priori confounders in an adjusted model. A
significance level of 0.05 was used for all hypothesis tests.
Results
A total of 467 FSW were enrolled. The presence of
cervicitis was unable to be assessed in 70 women due to
menses, pessary use, hysterectomy or other examination
difficulties. Cervicitis was present in 24.9% (99/397) of
the remaining participants. Table 1 presents the socio-
demographic, behavioral and biological characteristics,
including frequency of STI and other genital tract infec-
tions, in those FSW with and without cervicitis. In the
women with cervicitis, CT was present in 4.6% (4/87),
TV in 4.0% (4/99), GC in 0% (0/87) and no pathogen
was detected on cervical microbiology in 91.9% (91/99).
There were nil cervical co-infections detected. Bacterial
vaginosis was detected on vaginal microbiology in 36.9%
(31/84) of cervicitis cases for whom a definitive BV diag-
nosis could be made. Bivariate analyses of associations
between sociodemographic and biological variables with
cervicitis are presented in Table 2. Regular use of
healthcare services and Ecuadorian nationality were sig-
nificantly associated with a reduced risk of cervicitis,
even after multivariate analysis. BV was more common
in women with cervicitis, however this association did
not reach statistical significance (aOR = 1.47 [0.87, 2.48],
p = 0.15).
Further analyses were conducted to examine the associ-
ation between cervicitis and regular clinic attendance,
Ecuadorian nationality, and BV. The most common STI as-
sociated with cervicitis, namely CT, GC and TV, were less
common in regular clinic attendees (OR = 0.39 [0.15, 0.99],
p = 0.04). BV was also less common in regular clinic
attendees (OR = 0.39, 95% [0.24, 0.62] p < 0.001). Regular
clinic attendance was more common in Ecuadorian FSW
(OR = 2.72, [1.49, 4.94], p = 0.001).
Discussion
Almost one quarter of FSW in this study had cervicitis,
second only to vaginal discharge as the most common
syndrome. Cervicitis in this study was predominantly non-
gonococcal, non-chlamydial in etiology, and no pathogen
was detected in cervical samples in over 90% of partici-
pants with cervicitis. Cervicitis that is not associated with
chlamydial or gonoccocal infections is the most common
type of cervicitis overall and is referred to as ‘non-specific
cervicitis’ (NSC) [1]. The rate of NSC determined here was
higher than some rates reported in non-FSW women [6].
Studies in other FSW populations have demonstrated
a strong association between gonoccoal, chlamydial or
Trichomonas infection with clinical manifestations of
cervicitis [8,9]. No such association was found in the
women studied here, and this likely reflects the low
overall prevalence of STI diagnosed, in contrast to the
higher STI prevalence reported in FSW in other Latin
American countries, Asia and Africa [8,9,11,16,17].
Table 1 Sociodemographic, behavioral and biological characteristics in FSW with and without cervicitisa (Continued)
Clinical diagnoses and syndromes
Vaginal discharge 48 50.0 151 59.5 0.11
Genital ulcer 0 0.0 3 1.0 0.32
Pelvic Inflammatory Disease (PID) 4 4.0 9 3.0 0.62
aNumbers may not sum to total n due to missing values.
bInter-quartile range.
cEcuador (n = 63), Colombia (n = 11), Dominican Republic (n = 3).
dIncluded clandestine brothels, bars, hostels, street and telephone.
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Table 2 Associations between cervicitis and sociodemographic, behavioral and biological characteristics
Characteristic Unadjusted OR (95% CI) p value Adjusted OR (95% CI) p value
Age (years) 1.03 (1.00, 1.06) 0.02 1.01 (0.99, 1.04)a 0.32
Age at first sex 1.03 (0.94, 1.13) 0.53 1.02 (0.93, 1.12)a 0.66
Age of starting sex work 1.02 (0.98, 1.05) 0.33 0.99 (0.96, 1.03)a 0.72
Drug and/or alcohol use 1.01 (0.56, 1.82) 0.98 0.79 (0.43, 1.44)a 0.44
Earnings per client 1.00 (1.00, 1.01) 0.11 1.00 (1.00, 1.01)a 0.13
History of STI 1.26 (0.75, 2.09) 0.38 1.20 (0.70, 2.05)a 0.52
Illegal workplace 1.76 (0.96, 3.25) 0.07 1.48 (0.77, 2.84)a 0.24
Registered 0.65 (0.37, 1.15) 0.14 1.58 (0.63, 4.01)g 0.33
Months doing sex work 1.00 (1.00, 1.01) 0.03 1.00 (1.00, 1.01)a 0.1
Regularly receives medical care 0.48 (0.30, 0.77) <0.01 0.54 (0.34, 0.87)a 0.01
Has a non-client sexual partner 1.39 (0.87, 2.24) 0.17 1.42 (0.86, 2.33)a 0.17
Number of clients per week
None 1.00 (Ref) _ 1.00 (Ref) _
1 to 10 1.42 (0.79, 2.55) 0.24 1.33 (0.73, 2.41)b 0.35
11 to 20 1.57 (0.80, 3.09) 0.19 1.45 (0.72, 2.90)b 0.3
21 to 40 0.47 (0.19, 1.14) 0.1 0.42 (0.17, 1.04)b 0.06
> 40 0.45 (0.19, 1.09) 0.08 0.49 (0.20, 1.20)b 0.12
Condom use with clients (always) 0.77 (0.43, 1.38) 0.38 0.84 (0.46, 1.54)a 0.58
Condom use with clients or non-client partners (never) 1.35 (0.42, 4.33) 0.62 _ _
Condom use with non-client partners (always) 0.95 (0.82, 1.09) 0.48 0.50 (0.17, 1.48)c 0.21
Use of oral contraceptive pill 1.11 (0.62 - 1.98) 0.74 1.33 (0.72, 2.45)a 0.36
Education
Primary or less 0.95 (0.41, 2.17) 0.9 0.87 (0.36, 2.10)a 0.76
Secondary, incomplete 1.02 (0.61, 1.70) 0.94 0.98 (0.55, 1.72)a 0.93
Secondary complete 1.00 (Ref) _ 1.00 (Ref) _
Technical School 0.74 (0.29, 1.64) 0.41 0.62 (0.25, 1.53)a 0.3
University 0.63 (0.23, 1.70) 0.36 0.47 (0.15, 1.44)a 0.19
Nationality
Peruvian 1.00 (Ref) _ 1.00 (Ref) _
Ecuadorian 0.27 (0.11, 0.64) <0.01 0.31 (0.13, 0.76)a 0.01
Columbian or Dominican 0.8 (0.22, 2.94) 0.74 0.67 (0.18, 2.47)a 0.54
Sexual practices
Vaginal/Oral 1.00 (Ref) 1.00 (Ref)
Vaginal 2.05 (0.81, 5.17) 0.13 1.95 (0.72, 5.30)a 0.19
Vaginal/Oral/Anal 0.87 (0.48, 1.57) 0.65 0.84 (0.45, 1.56)a 0.58
Genital tract infections
Bacterial Vaginosis (BV) 1.50 (0.89, 2.52) 0.12 1.47 (0.87, 2.48)f 0.15
Chlamydia trachomatis (CT) 0.94 (0.29, 3.03) 0.91 _ _
Any cervicitis-causing STId 1.78 (0.72, 4.39) 0.21 _ _
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Other potential reasons for the high frequency of NSC
and lack of association with typical cervicitis-causing or-
ganisms may include ongoing inflammation of the cervix
after previously treated chlamydial or gonorrhoeal infec-
tions, perhaps mediated by an abnormal immune response
[2]. Data was unfortunately not collected on prior anti-
microbial treatment for cervicitis or other genital tract
syndromes in these women, which is a significant limita-
tion to this study.
Cervical irritation due to douches and spermicides may
also have contributed to high NSC rates [2]. While no data
was collected on the use of spermicides or frequency of
douching, douching is common in this population (per-
sonal observation by authors). Additionally, testing for
other potential pathogens associated with cervicitis such
as HSV-2 and M. genitalium were not performed in this
study [1]. Furthermore, microscopy was used for the de-
tection of trichomoniasis in this study, a method that is
less sensitive compared to culture-based, molecular and
immunochromatographic methods [3]. This relatively in-
sensitive method of TV detection is a limitation of this
study, and future studies should consider the use of newer
generation diagnostic methods such as PCR.
Bacterial vaginosis may play a causative role in some
NSC cases. BV was the second most common genital
tract infection in our study and was present in over a
third (36.9%) of cervicitis cases. On bivariate analysis,
the association between BV and cervicitis failed to reach
significance, but this may reflect insufficient power due
to the number of FSW enrolled. There is growing evi-
dence from other studies that BV is an independent risk
factor for cervicitis [6]. Bacterial vaginosis could lead to
cervicitis through a loss of bactericidal H202-producing
lactobacilli, reduced levels of protective vaginal mucins,
and increased pro-inflammatory enzymes and cytokines,
which in turn may decrease the cervical mucus barrier [6].
Regular clinic attendance was associated with a 46%
reduced risk of cervicitis, possibly due to the reduced
rates of STI and BV noted in the regular clinic at-
tendees. This may reflect frequent and early antibiotic
treatment of genital tract syndromes and infections,
although the exact frequency of antibiotic treatment
was not determined. Self-treatment with antimicrobials
was also considered as a confounding factor in women
who attended clinics, however only one participant
reported receiving treatment outside of clinics (data not
shown). Preventative STI education delivered during
clinic attendance may also contribute to the protective
effect associated with regular clinic attendance. Regard-
less of the mechanism, the current Peruvian Ministry of
Health program of free monthly health checks for FSW
may be effective for reducing rates of cervicitis, BV and
cervicitis-causing STI noted in FSW with regular clinic
attendance.
Ecuadorian nationality was also protective against cervi-
citis, even after controlling for regular clinic attendance,
which was more common in the Ecuadorian participants.
The effect of Ecuadorian nationality may reflect unmeas-
ured cultural differences in sexual practices, douching or
other risk behaviors for cervicitis and STI.
Conclusion
In conclusion, cervicitis was a common condition in
Peruvian FSW and in the context of very low STI rates
was predominately non-specific cervicitis. Our findings
may not be generalizable to other populations of FSW,
particularly those with higher rates of STI, but encour-
age further evaluation of the etiologies and treatment of
cervicitis in FSW populations. The protective effect of
Ecuadorian nationality is intriguing, and future studies
could examine the effect of migration upon the sexual
health and risk behaviors of FSW. Defining the role of
M. genitalium, HSV and other emerging pathogens such
as Ureaplasma urealyticum, adenovirus and cytomegalo-
virus in FSW with cervicitis may also reveal new associa-
tions [2,3].
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SP developed manuscript and assisted in data analysis. MC performed data
collection and assisted in study logistics, data analysis and manuscript
development. KH analyzed data and contributed to manuscript
development. VS assisted in study logistics, data collection and manuscript
development. SM and JZ developed study design and logistics, assisted in
Table 2 Associations between cervicitis and sociodemographic, behavioral and biological characteristics (Continued)
Human Papillomavirus 0.95 (0.59, 1.53) 0.84 0.96 (0.60, 1.55)f 0.87
HTLVe 1.83 (0.43, 7.81) 0.41 1.90 (0.45, 8.12)f 0.39
Pelvic Inflammatory Disease 1.35 (0.41, 4.49) 0.62 1.34 (0.40, 4.45)f 0.64
Vaginal discharge 0.68 (0.43, 1.09) 0.11 0.67 (0.42, 1.08)f 0.10
aAdjusted for receipt of regular medical care and nationality.
bAdjusted for nationality.
cAdjusted for age, earnings, and regular medical care.
dC. Trachomatis, N. Gonorrhoea, T. vaginalis.
eHuman T-cell Lymphotropic Virus.
fAdjusted for presence of any cervicitis-causing STI.
gAdjusted for receipt of regular medical care.
Pollett et al. BMC Infectious Diseases 2013, 13:195 Page 6 of 7
http://www.biomedcentral.com/1471-2334/13/195
data analysis and assisted in manuscript development. All authors read and
approved the final manuscript.
Acknowledgements
Some descriptive data from this manuscript was presented in the form an
abstract and oral presentation at the IUSTI 26th European Congress, 2011;
and aspects of the analysis and discussion were presented at the IDSA
Annual Scientific Conference in 2012. We wish to acknowledge the
assistance of all CSAB clinic staff and NAMRU-6 laboratory staff. The authors
also wish to thank all FSW who participated in this study.
Disclaimer
The views expressed in this article are those of the authors and do not
necessarily reflect the official policy or position of the Department of the
Navy, Department of Defense, nor the U.S. Government. Dr SM Montano is a
US Government Employee. This work was prepared as part of her official
duties. Title 17 U.S.C. §105 provides that ‘Copyright protection under this title
is not available for any work of the United States Government.’ Title 17 U.S.C.
§101 defines a U.S. Government work as a work prepared by a military
service member or employee of the U.S. Government as part of that person’s
official duties.
Funding statement
This study was supported by NIH Grants K23-AI01600, TW00679, AI0714P,
Fogarty International Grant T22-TW00001, and the University of Washington
Center for AIDS Research (CFAR) Grant AI27757.
Author details
1Bacteriology Department, U.S. Naval Medical Research Unit No. 6, Callao,
Peru. 2Sydney Emerging Infections and Biosecurity Institute, University of
Sydney, Sydney, Australia. 3Universidad Nacional Mayor de San Marcos, Lima,
Peru. 4DIRESA Callao, Centro de Salud ‘Alberto Barton’, Lima, Peru.
5Department of Epidemiology, University of Washington, Seattle, WA, USA.
6Department of Global Health and Neurology, University of Washington,
Seattle, WA, USA.
Received: 20 September 2012 Accepted: 1 April 2013
Published: 30 April 2013
References
1. Lusk MJ, Konecny P: Cervicitis: a review. Curr Opin Infect Dis 2008,
21(1):49–55.
2. Marrazzo JM, Martin DH: Management of women with cervicitis.
Clin Infect Dis 2007, 44(Suppl 3):S102–S110.
3. Workowski KA, Berman S: Sexually transmitted diseases treatment
guidelines. MMWR Recomm Rep 2010, 59(RR-12):1–110.
4. Zunt JR, et al: Cervical shedding of human T cell lymphotropic virus type
I is associated with cervicitis. J Infect Dis 2002, 186(11):1669–1672.
5. Kreiss J, et al: Association between cervical inflammation and cervical
shedding of human immunodeficiency virus DNA. J Infect Dis 1994,
170(6):1597–1601.
6. Marrazzo JM, et al: Risk factors for cervicitis among women with bacterial
vaginosis. J Infect Dis 2006, 193(5):617–624.
7. Ryan KA, et al: Prevalence and prediction of sexually transmitted diseases
among sex workers in Cameroon. Int J STD AIDS 1998, 9(7):403–407.
8. Pepin J, et al: Mycoplasma genitalium: an organism commonly associated
with cervicitis among west African sex workers. Sex Transm Infect 2005,
81(1):67–72.
9. Mukenge-Tshibaka L, et al: Syndromic versus laboratory-based diagnosis
of cervical infections among female sex workers in Benin: implications of
nonattendance for return visits. Sex Transm Dis 2002, 29(6):324–330.
10. Behets FM, et al: Evidence-based treatment guidelines for sexually
transmitted infections developed with and for female sex workers.
Trop Med Int Health 2003, 8(3):251–258.
11. Estrategia Sanitaria Nacional Prevención y Control de Infecciones de
Transmisión Sexual y VIH-SIDA-Lima: Guía Nacional de Manejo de Infecciones
de Transmisión Sexual. Peru: Ministerio de Salud; 2006.
12. Morton AN, et al: An outreach programme for sexually transmitted
infection screening in street sex workers using self-administered
samples. Int J STD AIDS 1999, 10(11):741.
13. Dallabetta GA, et al: Problems, solutions, and challenges in syndromic
management of sexually transmitted diseases. Sex Transm Infect 1998,
74:S1.
14. Gravitt PE, et al: Genotyping of 27 human papillomavirus types by using
L1 consensus PCR products by a single-hybridization, reverse line blot
detection method. J Clin Microbiol 1998, 36(10):3020–3027.
15. Marrazzo JM, et al: Bacterial vaginosis: identifying research gaps.
Proceedings of a workshop sponsored by DHHS/NIH/NIAID November
19–20, 2008. Sex Transm Dis 2010, 37(12):732–744.
16. Nguyen TV, et al: Sexually transmitted infections and risk factors for
gonorrhea and chlamydia in female sex workers in Soc Trang, Vietnam.
Sex Transm Dis 2008, 35(11):935–940.
17. Bautista CT, et al: Sexual practices, drug use behaviors, and prevalence of
HIV, syphilis, hepatitis B and C, and HTLV-1/2 in immigrant and non-
immigrant female sex workers in Argentina. J Immigr Minor Health 2009,
11(2):99–104.
doi:10.1186/1471-2334-13-195
Cite this article as: Pollett et al.: Prevalence and predictors of cervicitis
in female sex workers in Peru: an observational study. BMC Infectious
Diseases 2013 13:195.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Pollett et al. BMC Infectious Diseases 2013, 13:195 Page 7 of 7
http://www.biomedcentral.com/1471-2334/13/195
